Navigation Links
How chemotherapy becomes more effective
Date:3/5/2012

This release is available in German.

Researchers from the University of Zurich have found a cellular brake that protects cancer cells from chemotherapy -- and they demonstrate which medication can be used to render it inoperative. Their study published in the journal Natural Structural and Molecular Biology provides the molecular basis for promising therapeutic advances.

Although many cancer drugs have already been in use for decades, their mode of action is still unknown. The new research results now challenge a mechanism of action that was previously proposed for a group of drugs and supported with experiments: the Topoisomerase I-inhibitor Camptothecin (Top1 inhibitor for short) and its derivatives used in chemotherapy, Topotecan and Irinotecan.

Problem: emergency cellular brake restricts effectiveness

For a long time, the toxicity of the top1-inhibitors was attributed to discontinuities in the cancer cells' DNA that inevitably caused breaks in the chromosomes during the duplication of the DNA. The team headed by Professor Massimo Lopes at the University of Zurich's Institute of Molecular Cancer Research has now identified a mechanism with which cancer cells protect themselves against damage caused by Top1 inhibitions: Using electron microscopy, the researchers were able to demonstrate that Top1 inhibitors can cause the replication forks that develop during the duplication of the DNA to be restructured. "Reversed" replication forks, or "chicken-foot" structures as they are also known, are formed. This remodeling of the replication forks provides the cancer cells with the time they need to repair the lesion in the DNA and thus prevent disparately cytotoxic chromosomal breakage.

"Until now, the assumed mechanism of action of Top1 inhibitors was comparable to a train hurtling towards an obstacle without brakes that inevitably ends up derailing," explains Massimo Lopes, commenting on the results. "What we have now discovered is the emergency brake, which the cells activate themselves to protect themselves from the inhibitor." Arnab Ray-Chaudhuri, who made a considerable contribution to the study, draws the following conclusion: "Thanks to the discovery of this mechanism, we now understand why chemotherapy does not always work as expected with these drugs."

The existence of such DNA structures was hypothesized many years ago, but it has only just been confirmed in human cells by Lopes's group. These chicken-foot structures are even surprisingly common with clinically relevant doses of Top1 inhibitors.

Solution: render emergency brake inoperative

The new observations reveal an interesting coincidence: In pulling the emergency brake, a family of enzymes that recently attracted a great deal of interest as a potential target for new cancer therapies is involved in the restructuring: the poly-ADP-ribose polymerases, or PARPS for short. After all, PARP inhibitors increase the sensitivity of cancer cells to different drugs that harm the DNA, including Top1 inhibitors. The new study reveals why: PARP inhibition hinders the reversal of the replication forks and increases the number of chromosomal breaks caused by Top1 inhibitors. Massimo Lopes and his team thus provide a clear molecular basis for the clinical observations described and pave the way for promising therapeutic advances.

Massimo Lopes's team is currently investigating whether the same or a similar mechanism is activated by other classes of chemotherapeutics and which cellular factors are involved in this molecular "emergency brake". The aim is to identify tumors in which this mechanism is not active or inhibit the mechanism pharmacologically to improve the efficacy of chemotherapy.


'/>"/>

Contact: Massimo Lopes
lopes@imcr.uzh.ch
41-044-635-3467
University of Zurich
Source:Eurekalert

Related medicine news :

1. First study on long-term cognitive effects of breast cancer chemotherapy finds subtle impairment among women who received CMF regimen
2. Aurora-A hinders tumor-suppressor to allow chemotherapy resistance
3. Radiation plus chemotherapy provides long-term positive results for head and neck cancer patients
4. More Evidence for Oxaliplatin as Colon Cancer Chemotherapy
5. Selectively stopping glutathione sensitizes brain tumors to chemotherapy
6. Acupuncture Might Ease Chemotherapy Pain
7. Childhood cancer survivors exposure to chemotherapy, radiation does not increase risk of birth defects in their children
8. Predicting resistance to brain tumor chemotherapy
9. Survival rates increase with chemotherapy alone in patients with limited-stage Hodgkins lymphoma
10. Penn researchers repair immune system in leukemia patients following chemotherapy
11. Mayo Clinic researchers find drug duo kills chemotherapy-resistant ovarian cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... University Orthopedics ... Orthopedic Surgery, Division of Hand, Upper Extremity and Microvascular Surgery at Newport Hospital. ... board-certified in both Orthopedics and Hand Surgery. , As the leader of ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... protection assistance and financial consultations to families and business owners in the greater ... for the local American Cancer Society Relay For Life event. , Each year, ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Zabbia Insurance Agency, ... families and business owners in the greater Nassau County area, is embarking on ... , Every 3 minutes, someone in America is diagnosed with blood cancer. Every ...
(Date:3/22/2017)... ... ... HumanHaus is proud to announce the launch of its newest invention on ... was invented, but our customers today are busy, energetic, multi-taskers that live in a ... nesters and retired that want to travel. The Sweep&Stand is a self-standing ...
(Date:3/22/2017)... San Diego, CA (PRWEB) , ... March 22, 2017 , ... ... Specialty Health Inc. as one of San Diego’s Best and Brightest in Wellness® ... innovative healthcare strategies and its model use of best practices in wellness for its ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , March 22, 2017  Varex Imaging Corporation ... entered into a renewed three-year pricing agreement with Toshiba ... supply its computed tomography (CT) tubes for integration into ... This renewed agreement will be effective April 1, 2017. ... this renewed agreement are estimated to be in the ...
(Date:3/22/2017)... Ill. , March 22, 2017 ... innovative solutions for patients who suffer from advanced ... management team. Recent hires include experienced medtech executives ... (CMO), Richard Powers , Chief Information Officer ... of Manufacturing and Operations, who bring a wealth ...
(Date:3/22/2017)... SAN DIEGO , March 22, 2017 /PRNewswire/ ... company, announced today that it has entered into ... direct placement of 1,312,000 shares of common stock ... aggregate gross proceeds of $3,148,800.  The offering is ... 2017, subject to satisfaction of customary closing conditions. ...
Breaking Medicine Technology: